Mesoblast Ltd
MESO· Nasdaq
MESOMesoblast Ltd
Source filing unavailable
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $2.21M | $1.87M | $13.40M |
| Net Income | -$24.58M | -$24.60M | $13.70M |
| EPS Diluted | -$0.05 | -$0.05 | $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesoblast Ltd · CIK 1345099 · Engraved from SEC EDGAR
